Search

everythinglearnresearchcommunity

for

Search:↓

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

TPA is about 50 times more effective at promoting tumors than MZ.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

TCDD changes skin cell growth and keratin production in mice.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Active oxygen species might be involved in skin tumor growth, but their exact role is unclear.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

Increasing SSAT makes skin more prone to cancer.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

IL-1β inhibits human hair follicle growth.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

Proteolytic activity in mouse skin changes with hair cycle stages, peaking in early anagen.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Hair follicle cultures are effective for studying cell communication and testing chemicals.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Lrig1 and Lgr6 stem cells help maintain hair follicles and influence skin cancer development.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

The HPV type 11 region activates hair-specific gene expression in mice.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.